Loading organizations...
Loading organizations...
Key people at capital300.
Capital300, now known as 3VC, operates as a European venture capital fund, strategically deploying capital into early-stage technology companies. The firm focuses on Series A investments, partnering with carefully selected startups that demonstrate global ambition. Its approach emphasizes quality partnerships, robust support for founders throughout their growth journey, and a commitment to responsible investing principles.
The fund was established in 2017 as Capital300 by Roman Scharf and Peter Lasinger. Their founding insight stemmed from a deep understanding of the entrepreneurial path, having experienced the challenges and triumphs of building companies themselves. This personal experience shapes their philosophy to provide comprehensive support beyond mere capital, aiming to be true partners to founders.
3VC serves an ecosystem of ambitious tech startups across Europe, providing not just funding but also strategic guidance to navigate growth. The firm's long-term vision centers on fostering lasting impact through innovation, identifying and backing disruptive technologies. They aim to prepare companies for a future shaped by digitalization, emphasizing thoughtful and values-driven investment decisions.
Key people at capital300.
capital300 (now rebranded as 3VC) is a Vienna-based venture capital firm that focuses on early-stage technology startups, primarily in Europe. Their mission is to fuel innovation and entrepreneurship by providing funding and strategic guidance to promising startups, particularly those with global scalability potential. The firm invests mainly at Seed and Series A stages, targeting sectors such as fintech, artificial intelligence (AI), health tech, and blockchain. By backing disruptive technology companies, capital300 aims to accelerate growth and innovation within the European startup ecosystem, supporting founders with both capital and operational expertise[1][3][5].
Founded in 2017 by Roman Scharf and Peter Lasinger, capital300 emerged with a vision to invest in European tech startups that demonstrate strong potential for global impact. The founders brought extensive experience in private equity and mid-market investments, particularly in technology and healthcare sectors. Over time, the firm evolved its focus to emphasize an operator-first investment approach, combining capital with hands-on management and operational improvements. This evolution reflects their commitment to unlocking value through active involvement and strategic support, which has led to successful exits and a growing portfolio of innovative companies[1][5].
capital300 rides the wave of increasing European tech innovation and the global push for digital transformation in sectors like fintech, AI, and health tech. The timing is favorable due to growing investor interest in European startups and the maturation of these technology sectors. By supporting startups from early stages, capital300 helps bridge the funding gap in Europe and fosters a more vibrant ecosystem. Their operator-first approach and cross-border experience position them as influential players in shaping the growth trajectory of European tech companies, contributing to the continent’s competitiveness on the global stage[1][3][6].
Looking ahead, capital300 (3VC) is likely to deepen its focus on scaling European startups with global ambitions, leveraging its operational expertise to help portfolio companies navigate growth challenges. Trends such as AI integration, blockchain adoption, and digital health innovation will continue to shape their investment strategy. As the European tech ecosystem matures, capital300’s role as a proactive, founder-centric investor will likely expand, potentially increasing their influence in driving innovation and cross-border tech collaborations. Their commitment to responsible investing and long-term partnerships suggests sustained impact in the venture capital landscape[6].
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 1, 2020 | Lokalise | $6.0M Series A | Mike Chalfen | 20VC, 3VC, Anti fund, Astir Ventures, Banana Capital, Bessemer Venture Partners, Buckley Ventures, Chalfen Ventures, Craft Ventures, Dawn Capital, Dragonfly Capital Partners, Earlybird Venture Capital, Foundation Capital, Founders Fund, Insight Partners, Kapor Capital, Kepler Operator’s Fund, Khosla Ventures, Kleiner Perkins, Long Journey Ventures, Pareto Holdings, Sequoia Capital, Charlie Songhurst, Dennis Chan, Jaan Tallinn, Josh Mohrer, Kunal Shah, Louis Beryl, Scott Banister, Shervin Pishevar, Alistair Russell, Andrey Khusid, Carlos Gonzalez-Cadenas, Charlie Songhurst, Des Traynor, Dominic Lewis, Eugene Katz, Matt Robinson, Nicolas Dessaigne, Rich Waldron, Stephane Kurgan, Eva Arh, Andrey Khusid |
| Jun 25, 2020 | FireStart | $4.5M Series A | capital300, Georg Stockinger | Ann-Kristin Achleitner, Charlie Songhurst, Paul Achleitner |
| Jun 1, 2020 | Kaia Health | $23.0M Series B | Optum Ventures, capital300, Idinvest Partners | 3VC, 50 Partners, Accel, Balderton Capital, BootstrapLabs, CapitalX, Draper Associates, Earl Grey Capital, Eunoia Capital Partners, Eurazeo, Expa, Heartcore Capital, Jude Gomila Rolling Fund, Outrun Ventures, Pareto Holdings, Pebblebed, Stride VC, Y Combinator, Alexandre Scialom, Alexis Le-Quoc, Chris Murphy, Eric Nadalin, Hanno Renner, Immad Akhund, Jean-Sébastien Wallez, Louis Beryl, Symphony Ventures |
| Jan 1, 2019 | Authenteq - an FNZ company | $5.0M Series A | Peter Lasinger, Tim Draper | 3VC, Draper Associates |